Advertisement
Advertisement
U.S. markets close in 5 hours 33 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
30.77-0.19 (-0.61%)
As of 10:26AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close30.96
Open30.85
Bid30.73 x 1000
Ask30.67 x 800
Day's Range30.03 - 30.88
52 Week Range12.80 - 50.54
Volume85,330
Avg. Volume1,878,587
Market Cap1.463B
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-1.96
Earnings DateNov 02, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PTGX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Protagonist Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/12/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
  • Insider Monkey

    Hedge Funds Are Crazy About Protagonist Therapeutics, Inc. (PTGX)

    At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of June 30th. In this […]

  • Zacks

    New Strong Sell Stocks for October 14th

    ARNC, BSET, FMS, OCUL, and PTGX have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2021.

  • TipRanks

    J.P. Morgan Says There’s Room for Over 40% Upside in These 2 Stocks

    Stuck for fresh investing inspiration? You’re not alone. Plenty of uncertainty lingers on Wall Street as we head into 2022. Inflation is up, the job market remains stuck in an ugly combination of stubborn unemployment and record-high levels of job openings, all while Congress and the Biden Administration are looking less and less capable of passing a set of aggressive spending plans. Writing from JPMorgan, global market strategist Marko Kolanovic acknowledges the headwinds but thinks there are p

Advertisement
Advertisement